There is an increasing concern that exchange-traded funds (ETFs) could be one of the products mis-sold to investors. In any industry where the seller has a lot more information about their product than the buyer, there is always the risk of mis-selling – because the salesperson knows too much and the customer too little.
This is why mis-selling tends to be prevalent in the pharmaceutical and finance industries………………………………………..Full Article: Source